[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
[Skip to Content Landing]
From the JAMA Network
July 28, 2015

Empirical Therapy of Community-Acquired PneumoniaAdvancing Evidence or Just More Doubt?

Author Affiliations
  • 1Department of Medicine, McMaster University, Hamilton, Ontario, Canada
  • 2Department of Medicine, University of Western Australia, Perth, Australia
  • 3Department of Medicine, Northwestern University, Chicago, Illinois
JAMA. 2015;314(4):396-397. doi:10.1001/jama.2015.3858

Pneumonia remains a significant cause of morbidity and mortality, whether community acquired (CAP) or hospital acquired. Although many microbial pathogens may cause pneumonia, the most commonly encountered are pneumococcus; atypical organisms, such as Mycoplasma pneumoniae or Legionella; and at times Staphylococcus aureus and certain gram-negative rods. As diagnostic tests have increased in availability and sophistication, identifying multiple pathogens in the same patient is increasingly common.

First Page Preview View Large
First page PDF preview
First page PDF preview